Coherus BioSciences Inc (CHRS) — Free Cash Flow Generation Index
Coherus BioSciences Inc (CHRS) has a Free Cash Flow Generation Index of 1.00x as of December 2024. Free cash flow of $28.61 Million represents 1% of operating cash flow ($28.61 Million). Explore reinvestment intensity of Coherus BioSciences Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Coherus BioSciences Inc Free Cash Flow Generation Index (2013–2020)
Historical FCF Generation Index trend for Coherus BioSciences Inc across 3 annual periods. For the full cash flow conversion analysis, see Coherus BioSciences Inc (CHRS) cash flow conversion.
Annual Free Cash Flow Generation for Coherus BioSciences Inc (2013–2020)
Year-by-year Free Cash Flow Generation Index for Coherus BioSciences Inc. Check how aggressively does Coherus BioSciences Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.95x | $146.91 Million | $154.15 Million | $7.23 Million | ▲ +74.8% |
| 2019 | 0.55x | $15.46 Million | $28.36 Million | $12.90 Million | ▼ -44.1% |
| 2013 | 0.98x | $15.05 Million | $15.42 Million | $373.00K | — |